Nine Monthly Results Results Snapshot
Figures in Cr
Consolidate Nine Monthly Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
2,372.86
2,188.34
1,458.22
1,282.35
1,041.09
933.66
825.50
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,372.86
2,188.34
1,458.22
1,282.35
1,041.09
933.66
825.50
Raw Material Cost
258.53
208.06
126.64
109.66
87.56
77.34
52.87
Purchase of Finished goods
367.59
377.14
143.00
151.84
100.37
135.97
56.41
(Increase) / Decrease In Stocks
-15.77
-41.46
-7.78
18.11
8.77
-35.47
25.16
Employee Cost
419.96
383.64
301.35
260.35
188.79
176.79
150.09
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
-0.02
0.01
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
496.02
496.15
368.61
324.55
267.55
242.98
249.84
Total Expenditure (Excl Depreciation)
1,526.33
1,423.53
931.82
864.49
653.05
597.61
534.36
Operating Profit (PBDIT) excl Other Income
846.53
764.81
526.40
417.86
388.04
336.05
291.14
Other Income
5.52
10.41
8.67
10.15
18.03
6.49
16.47
Operating Profit (PBDIT)
852.05
775.22
535.07
428.01
406.07
342.54
307.61
Interest
147.05
177.01
51.77
17.30
2.89
1.26
1.81
Exceptional Items
-17.24
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
687.76
598.21
483.30
410.71
403.18
341.28
305.80
Depreciation
209.93
237.42
128.71
81.96
46.34
31.52
35.94
Profit Before Tax
477.95
360.79
354.59
328.74
356.86
309.77
269.85
Tax
110.72
87.96
37.17
16.06
31.04
22.89
29.62
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
367.11
272.83
317.42
312.68
325.82
286.89
240.24
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
367.11
272.83
317.42
312.68
325.82
286.89
240.24
Share in Profit of Associates
1.29
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-12.28
-7.70
1.04
0.80
0.00
0.00
-0.01
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
337.90
258.53
321.03
316.74
325.82
286.89
240.23
Equity Capital
13.61
13.61
13.60
13.60
13.59
13.58
13.75
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Diluted Earnings per share
7.31
6.15
7.54
7.49
7.41
6.63
4.61
Operating Profit Margin (Excl OI)
35.68%
34.95%
36.1%
32.59%
37.27%
35.99%
35.27%
Gross Profit Margin
28.98%
27.34%
33.14%
32.03%
38.73%
36.55%
37.04%
PAT Margin
15.47%
12.47%
21.77%
24.38%
31.3%
30.73%
29.1%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Nine Monthly Analysis Highlights
Net Sales
YoY Growth in nine months ended Dec 2025 is 8.43% vs 50.07% in Dec 2024
Consolidate Net Profit
YoY Growth in nine months ended Dec 2025 is 30.70% vs -19.47% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in nine months ended Dec 2025 is 10.69% vs 45.29% in Dec 2024
Interest
YoY Growth in nine months ended Dec 2025 is -16.93% vs 241.92% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in nine months ended Dec 2025 has improved from Dec 2024
Compare Nine Monthly Results Of ERIS Lifescience With
Figures in Cr
Consolidate Nine Monthly Results
Change(INR)
Change(%)
Net Sales
2,372.86
993.37
1,379.49
138.87%
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,372.86
993.37
1,379.49
138.87%
Raw Material Cost
258.53
294.64
-36.11
-12.26%
Purchase of Finished goods
367.59
0.00
367.59
(Increase) / Decrease In Stocks
-15.77
6.14
-21.91
-356.84%
Employee Cost
419.96
182.99
236.97
129.50%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
496.02
297.30
198.72
66.84%
Total Expenditure (Excl Depreciation)
1,526.33
781.07
745.26
95.42%
Operating Profit (PBDIT) excl Other Income
846.53
212.30
634.23
298.74%
Other Income
5.52
12.93
-7.41
-57.31%
Operating Profit (PBDIT)
852.05
225.23
626.82
278.30%
Interest
147.05
99.67
47.38
47.54%
Exceptional Items
-17.24
-9.96
-7.28
-73.09%
Gross Profit (PBDT)
687.76
115.60
572.16
494.95%
Depreciation
209.93
207.27
2.66
1.28%
Profit Before Tax
477.95
-91.67
569.62
621.38%
Tax
110.72
-13.27
123.99
934.36%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
367.11
-78.40
445.51
568.25%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
367.11
-78.40
445.51
568.25%
Share in Profit of Associates
1.29
0.00
1.29
Minority Interest
-12.28
0.00
-12.28
Other related items
0.00
0.00
0.00
Consolidated Net Profit
337.90
-78.40
416.30
530.99%
Equity Capital
13.61
11.46
2.15
18.76%
Face Value
1.00
1.00
0.00
Reserves
0.00
0.00
0.00
Gross Profit Margin
28.98%
11.64%
0.00
17.34%
PAT Margin
15.47%
-7.89%
0.00
23.36%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 2,372.86 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 8.43% vs 50.07% in Dec 2024
Nine Monthly - Consolidate Net Profit
Consolidate Net Profit 337.90 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 30.70% vs -19.47% in Dec 2024
Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 846.53 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 10.69% vs 45.29% in Dec 2024
Nine Monthly - Interest
Interest 147.05 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is -16.93% vs 241.92% in Dec 2024
Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 35.68%
in Dec 2025Figures in %
YoY Growth in nine months ended Dec 2025 has improved from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
